Raymond James continues Biotechnology Investment Banking expansion, hires Senior Banker on West Coast

ST. PETERSBURG, Fla. ─ Raymond James has further expanded its Health Care Investment Banking practice with the addition of Titus Phoro as managing director. Based in Los Angeles, Phoro will focus on biotechnology.

“We are excited to welcome Titus to our team,” said Andrew Gitkin, co-head of Health Care Investment Banking. “He brings significant industry expertise and experience and is known for his thoughtful and results-oriented approach to assisting his clients. This approach is central to how we have strategically built our world-class team of biotechnology investment bankers.”

Phoro’s hire follows a number of significant additions to the biotechnology team, joining managing directors Bell Zhong and James Kim in Investment Banking and Brian Gleason in Equity Capital Markets.

Phoro has more than 15 years of biopharmaceutical experience, including almost a decade as an investment banker focusing on biotech clients. Most recently, he was a senior coverage banker at Stifel, focused on West Coast biotech clients, and previously worked at Jefferies, RBC and JMP Securities. Prior to beginning his investment banking career, Phoro worked as a registered pharmacist for CVS/Pharmacy and completed pharmacy rotations at the Texas Medical Center in Houston. He holds an MBA from the University of Chicago Booth School of Business and a Doctor of Pharmacy degree from Texas Southern University.

“I am excited to join the well-respected and growing team at Raymond James,” Phoro said. “Biotechnology’s critical role in society is more evident than ever before, and I look forward to serving our clients as they make groundbreaking advancements and forge new paths in the field.

About Raymond James Investment Banking
Raymond James Investment Banking offers highly regarded capital formation and financial advisory services. Since 2015, we have participated in raising nearly $280 billion in capital for our corporate clients and completed over 875 advisory assignments, including nearly 750 M&A buy-side or sell-side advisory assignments.

About Raymond James Financial, Inc.
Raymond James Financial, Inc. (NYSE: RJF) is a leading diversified financial services company providing private client group, capital markets, asset management, banking and other services to individuals, corporations and municipalities. The company has approximately 8,200 financial advisors throughout the United States, Canada and overseas. Total client assets are $930 billion. Public since 1983, the firm is listed on the New York Stock Exchange under the symbol RJF. Additional information is available at www.raymondjames.com.